Sequential and concomitant therapy with four drugs is equally effective for eradication of H pylori infection. - Wikidata - awgldk - TriplyDB

Sequential and concomitant therapy with four drugs is equally effective for eradication of H pylori infection.

Sequential and concomitant therapy with four drugs is equally effective for eradication of H pylori infection.

http://www.wikidata.org/entity/Q33727000

about

Treatment of Helicobacter pylori infection: Current and future insights Role of Helicobacter pylori infection in gastric carcinogenesis: Current knowledge and future directions Comparative effectiveness and tolerance of treatments for Helicobacter pylori: systematic review and network meta-analysis Global eradication rates for Helicobacter pylori infection: systematic review and meta-analysis of sequential therapy Does long-term use of silver nanoparticles have persistent inhibitory effect on H. pylori based on Mongolian gerbil's model?Treatment of Helicobacter pylori infection: current status and future concepts.Facing resistance of H.pylori infection Optimal treatment strategy for Helicobacter pylori: era of antibiotic resistance.Consensus on the clinical management, screening-to-treat, and surveillance of Helicobacter pylori infection to improve gastric cancer control on a nationwide scale.Levofloxacin-amoxicillin/clavulanate-rabeprazole versus a standard seven-day triple therapy for eradication of Helicobacter pylori infection "Concomitant" or "sequential" eradication of Helicobacter pylori: which regimen comes first?Hybrid Therapy versus Sequential Therapy for Eradication of Helicobacter pylori: A Randomized Controlled Trial.Update on the first-line treatment for Helicobacter pylori infection - a continuing challenge from an old enemy.Treatment of Helicobacter pylori infection 2011.Management of Helicobacter pylori infection in Latin America: a Delphi technique-based consensus Randomized controlled trial comparing 7-day triple, 10-day sequential, and 7-day concomitant therapies for Helicobacter pylori infection Modified sequential Helicobacter pylori therapy: proton pump inhibitor and amoxicillin for 14 days with clarithromycin and metronidazole added as a quadruple (hybrid) therapy for the final 7 days.Treatment of Helicobacter pylori infection: Past, present and future Concomitant therapy achieved the best eradication rate for Helicobacter pylori among various treatment strategies.Empiric therapies for Helicobacter pylori infections.Primary antibiotic resistance of Helicobacter pylori strains isolated from patients with dyspeptic symptoms in Beijing: a prospective serial study.A new look at anti-Helicobacter pylori therapy A randomized study comparing levofloxacin, omeprazole, nitazoxanide, and doxycycline versus triple therapy for the eradication of Helicobacter pylori Efficacy of moxifloxacin-based sequential therapy for first-line eradication of Helicobacter pylori infection in gastrointestinal disease.Comparison of Second-Line Quadruple Therapies with or without Bismuth for Helicobacter pylori Infection Seven-Day Nonbismuth Containing Quadruple Therapy Could Achieve a Grade "A" Success Rate for First-Line Helicobacter pylori Eradication.Update on non-bismuth quadruple (concomitant) therapy for eradication of Helicobacter pylori.14-day triple, 5-day concomitant, and 10-day sequential therapies for Helicobacter pylori infection in seven Latin American sites: a randomised trial.Hybrid therapy for Helicobacter pylori infection: A systemic review and meta-analysis.Efficacy of moxifloxacin-based sequential and hybrid therapy for first-line Helicobacter pylori eradication Newer agents for Helicobacter pylori eradication Hybrid vs sequential therapy for eradication of Helicobacter pylori in Taiwan: A prospective randomized trial.7-Day Nonbismuth-Containing Concomitant Therapy Achieves a High Eradication Rate for Helicobacter pylori in Taiwan.Efficacy of Probiotic Supplementation Therapy for Helicobacter pylori Eradication: A Meta-Analysis of Randomized Controlled Trials.Helicobacter pylori therapy: Present and future Advances in gastric cancer prevention.A Randomized Controlled Study Comparing Reverse Hybrid Therapy and Standard Triple Therapy for Helicobacter pylori Infection Mass Eradication of Helicobacter pylorito Prevent Gastric Cancer: Theoretical and Practical Considerations Comparing the Efficacy of Concomitant Therapy with Sequential Therapy as the First-Line Therapy of Helicobacter pylori Eradication.Comparison of three different regimens against Helicobacter pylori as a first-line treatment: A randomized clinical trial

P2860

Q26769707-B574663F-944F-4E77-98FD-4AA06DF35FA5 Q26778023-73EF4386-1853-406C-A2F1-031BF35B9636 Q26796367-FC77E87F-34A4-4C28-AAA6-3F300FE17C80 Q28296156-94EE8306-3D08-4798-A9CC-8C1B84A93C6F Q33593981-08E9E6E8-A6CA-4418-9766-B0F23BA6B7D7 Q33594850-7349A54F-2170-4718-9C6C-9F25B98D58F7 Q33596218-1C77D8C6-42F1-4DB9-83FE-3A912EE57E38 Q33626779-DE851DD1-6A7A-44E4-B316-EE9A57CEFDE8 Q33698340-3ACB9CCF-249A-4238-9196-98E6986C456D Q33790850-6919F31E-CC8C-440A-A012-EDF52A6995AE Q33813453-9545D6F8-28C9-4F3C-AB83-8CC0E0774600 Q33872245-C3C158DB-7A1F-44C8-A9E8-B7CA37C04643 Q33893567-7066BE52-1066-4CBE-8B89-E4D3151A009E Q34028419-A91CD11E-3CF1-4200-A93C-EB9232CA42EA Q34067951-B34BFF8F-1F82-499D-9C6E-9C17C2C43916 Q34299125-970AC429-DA1A-4778-A63E-9A84FEF5087B Q34314718-8524C024-B1DD-47F7-84E2-3BE3D062B37D Q34508830-82CD55CE-D10E-42C2-A2F2-80C1623B2499 Q34827671-01468A1A-F85E-4E43-B7D2-2FF0A3515C0D Q35045027-D2CCF965-6F56-42BA-9AED-DC0338EEBF2F Q35152391-C9A1F59B-D806-4B4A-B7DE-1192D08C7A12 Q35424549-A987FC27-C941-4E10-813B-E416DBE9A665 Q35532235-41036A13-00AB-4DF4-ADE3-BDAAAFFB374D Q35534113-0DDA530D-AD26-4DD2-8EC9-BA7278B38174 Q35668797-95AE9B86-687C-44AE-93C7-2F912AB2E9F8 Q35674499-C4C4F89C-BC32-486B-8EA9-B527F8399098 Q35841617-47F57F21-31F0-4D3F-B78E-812FF4474DB8 Q35855301-0BFB217E-F6EE-42D7-9120-A49421A63878 Q35868940-348CA66F-6F1B-4771-B6CF-E220619D7BE6 Q36067627-789073C2-7D62-4ADE-8668-C3903E05B58D Q36071019-6182A6A8-4796-4F1C-86BA-12E8184B4333 Q36085602-C378328E-C9CC-47AB-B560-89ABBCD5EB8F Q36129001-A16839BC-9C41-471E-95DC-C043473FEF64 Q36159208-4FB48D67-7E13-4AB6-AAD9-959BA6BE7D84 Q36220182-2224172A-55A9-41AC-9A35-BC5A18899099 Q36309968-674E3BC3-8467-436E-84D5-D7868B3C7A3D Q36359069-94CA1AD0-E74A-48CE-912C-015AB7DA8549 Q36412858-13CC56D8-7086-441A-832B-2BF5C7AD4F4E Q36448524-BA1746B0-8E6D-4855-96F0-F4C2DC161701 Q36614237-7DB79581-058D-457B-965A-77B14A32610F

P2860

Sequential and concomitant therapy with four drugs is equally effective for eradication of H pylori infection.

http://www.wikidata.org/entity/Q33727000

description

2009 nî lūn-bûn

@nan

2009 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած

@hyw

2009 թվականի հոտեմբերին հրատարակված գիտական հոդված

@hy

2009年の論文

@ja

2009年学术文章

@wuu

2009年学术文章

@zh-cn

2009年学术文章

@zh-hans

2009年学术文章

@zh-my

2009年学术文章

@zh-sg

2009年學術文章

@yue

name

Sequential and concomitant the ...... ication of H pylori infection.

@ast

Sequential and concomitant the ...... ication of H pylori infection.

@en

type

label

Sequential and concomitant the ...... ication of H pylori infection.

@ast

Sequential and concomitant the ...... ication of H pylori infection.

@en

prefLabel

Sequential and concomitant the ...... ication of H pylori infection.

@ast

Sequential and concomitant the ...... ication of H pylori infection.

@en

P1433

Q33727000-FF3C23D3-9D1F-4352-BC32-882B8922D167

P1476

Q33727000-8770E208-4AF2-4EF6-84FD-3C46AFDEEA98

P2093

Q33727000-00F1CDEA-8B65-4537-BB06-4E3F6D5F45B9

Q33727000-026EEA52-6EB9-44B1-A0CC-A8A89FA33B09

Q33727000-06958D64-F60F-40AA-B8C1-C8B94F1E8BDE

Q33727000-080A078A-EF08-48A5-B41F-A7B43DA4B159

Q33727000-51B5CFCD-1752-4274-B4F0-52775A861925

Q33727000-579D0612-3F35-4B63-A441-BFC9DAB0F4C8

Q33727000-A477B9BD-52BB-4533-A0E5-80043E5ED421

Q33727000-B86D6F14-A241-4122-8307-C6E2B7582189

Q33727000-C56E96F3-295A-438F-A09F-ADAF8DE188E9

P2860

Q33727000-010EC55E-DAF9-4BD8-B19B-CE5F48AD597C

Q33727000-030F72C2-1F30-4FCB-8D8A-541D273EFD07

Q33727000-193564FD-C6FB-40EA-88CF-767E47A51998

Q33727000-1A8128D5-031B-47F8-BC31-AC6279C2B18B

Q33727000-1D89E81F-AA14-4170-A8A1-CE2C91572486

Q33727000-1E6CC554-4C99-4516-9FD6-E15F2CCB6248

Q33727000-262BCA36-68FB-4D75-850C-315FAA2758E7

Q33727000-2F7E3227-6B2B-43E6-8938-BA09B76A6032

Q33727000-317295F2-87D5-44C0-8D59-2D578B701654

Q33727000-34B13925-DD74-4756-A971-3D6DECC71FAC

P304

Q33727000-AE46C09A-4309-4369-A176-7BF128C1461E

P31

Q33727000-D852B913-117F-4D85-968E-662AB569DC46

P356

Q33727000-889DE857-949B-4EA9-99C1-482E15A06449

P407

Q33727000-C305FC64-CEA4-4B46-863C-4DDBA8BF6329

P433

Q33727000-8675DA01-7660-4946-87EE-C482779148D6

P478

Q33727000-865F2A62-2F6F-475A-B9A1-0D03B255AF18

P50

Q33727000-E94C4F19-C633-4DD9-941C-F3841DEF5A98

P577

Q33727000-9BBB967F-2C97-49D0-A919-EB13ABEC9479

P5875

Q33727000-66AA419F-6368-4786-9DAE-291A6A1FA33D

P698

Q33727000-D2CB326F-C19E-4A6B-A042-6C45D8D9CCBA

P921

Q33727000-43827402-4C6C-43F8-8DD9-746315BC14B6

Q33727000-F795EF42-A55D-4618-9130-F76EB29D7440

P932

Q33727000-09747674-A9B8-47A8-B1B7-5B415FFBBA88

P356

J.CGH.2009.09.030

P1433

Clinical Gastroenterology and Hepatology

P1476

Sequential and concomitant the ...... ication of H pylori infection.

@en

P2093

Angela Chen

http://www.w3.org/2001/XMLSchema#string

Antone R Opekun

http://www.w3.org/2001/XMLSchema#string

Chao-Hung Kuo

http://www.w3.org/2001/XMLSchema#string

Deng-Chyang Wu

http://www.w3.org/2001/XMLSchema#string

I-Chen Wu

http://www.w3.org/2001/XMLSchema#string

Jeng-Yih Wu

http://www.w3.org/2001/XMLSchema#string

Ping-I Hsu

http://www.w3.org/2001/XMLSchema#string

Sophie S W Wang

http://www.w3.org/2001/XMLSchema#string

Wen-Chun Hung

http://www.w3.org/2001/XMLSchema#string

P2860

New concepts of resistance in the treatment of Helicobacter pylori infections

Current concepts in the management of Helicobacter pylori infection: the Maastricht III Consensus Report

Risk factors for failure of Helicobacter pylori therapy--results of an individual data analysis of 2751 patients.

Why is long-term therapy required to cure tuberculosis?

Meta-analysis: duration of first-line proton-pump inhibitor based triple therapy for Helicobacter pylori eradication.

Meta-analysis: four-drug, three-antibiotic, non-bismuth-containing "concomitant therapy" versus triple therapy for Helicobacter pylori eradication

Meta-analysis: the effect of antibiotic resistance status on the efficacy of triple and quadruple first-line therapies for Helicobacter pylori.

Helicobacter pylori: the challenge in therapy.

Comparison of 1 and 2 weeks of omeprazole, amoxicillin and clarithromycin treatment for Helicobacter pylori eradication: the HYPER Study.

Eradication therapy for Helicobacter pylori.

P304

36-41.e1

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1016/J.CGH.2009.09.030

http://www.w3.org/2001/XMLSchema#string

P407

P433

1

http://www.w3.org/2001/XMLSchema#string

P478

8

http://www.w3.org/2001/XMLSchema#string

P50

David Y. Graham

P577

2009-10-03T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

26871022

http://www.w3.org/2001/XMLSchema#string

P698

19804842

http://www.w3.org/2001/XMLSchema#string

P921

eradication of infectious diseases

Helicobacter pylori

P932

2838430

http://www.w3.org/2001/XMLSchema#string